N3 alkylated benzimidazole derivatives as mek inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4184 (2006.01) C07D 235/08 (2006.01)

Patent

CA 2537098

Disclosed are compounds of the formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R1, R2, R7, R8, R9, and R10 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds.

Cette invention concerne des composés représentés par la formule (I) ainsi que des sels et des promédicaments pharmaceutiquement acceptables de ces composés. Dans cette formule, W, R?1¿, R?2¿, R?7¿, R?8¿, R?9¿ et R?10¿ sont tels que définis dans la description. Ces composés sont des inhibiteurs de MEK et servent au traitement de maladies hyperprolifératives, telles que le cancer et l'inflammation, chez les mammifères. Cette invention concerne en outre un procédé d'utilisation de ces composés dans le traitement de maladies hyperprolifératives chez les mammifères ainsi que des compositions pharmaceutiques contenant ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

N3 alkylated benzimidazole derivatives as mek inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N3 alkylated benzimidazole derivatives as mek inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N3 alkylated benzimidazole derivatives as mek inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1896669

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.